别名 hTRP-5、hTRP5、PPP1R159 + [8] |
简介 Forms a receptor-activated non-selective calcium permeant cation channel (PubMed:16284075, PubMed:38959890). Probably is operated by a phosphatidylinositol second messenger system activated by receptor tyrosine kinases or G-protein coupled receptors. Has also been shown to be calcium-selective (By similarity). May also be activated by intracellular calcium store depletion. Mediates calcium-dependent phosphatidylserine externalization and apoptosis in neurons via its association with PLSCR1 (By similarity). Acts on distinct neuronal populations in the hypothalamus to regulate innate behaviors including feeding, anxiety (flight/fight/fear), socialization, and maternal care (By similarity). |
靶点 |
作用机制 TRPC5抑制剂 |
在研机构- |
原研机构 |
在研适应症 |
非在研适应症- |
最高研发阶段批准上市 |
首次获批国家/地区- |
首次获批日期1800-01-20 |
作用机制 5-HT receptor调节剂 [+2] |
在研适应症 |
非在研适应症 |
最高研发阶段临床3期 |
首次获批国家/地区- |
首次获批日期1800-01-20 |
作用机制 TRPC4抑制剂 [+1] |
最高研发阶段临床2期 |
首次获批国家/地区- |
首次获批日期1800-01-20 |
开始日期2025-04-08 |
申办/合作机构 |
开始日期2023-10-19 |
开始日期2023-09-08 |
申办/合作机构 |